Pleiotropic effects of statins: Do they matter?

Current Opinion in Lipidology

Volumn 12, Issue 4, 2001, Pages 391-394

  Gotto Jr , Antonio M ^a   Farmer, John A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; TIROFIBAN; VASODILATOR AGENT;

ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; META ANALYSIS; MORTALITY; PLEIOTROPY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; SURVIVAL;

ANIMALS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; LOVASTATIN; THROMBOSIS;

EID: 0034924777     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200108000-00004     Document Type: Review

References (30)

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
2. Primary prevention of acute coronary events with Iovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
6. Lipid-lowering interventions in angiographic trials
7. Atherosclerotic plaque rupture: Emerging insights and opportunities
8. Low-density lipoprotein-independent effects of statins
9. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering
10. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
11. Pleiotropic effects of statins in atherosclerosis and diabetes
12. Cardiovascular benefits of cholesterol lowering therapy: Does improved endothelial vasodilator function matter?
13. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women
14. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
15. Vitamin E supplementation and cardiovascular events in high risk patients
16. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types
17. Early statin treatment following acute myocardial infarction and one-year survival
18. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial
19. Simvastatin increases in vitro bone formation in mice murine calvaria
20. Inhibitors of hydroxymethyglutaryl-coenzyme A reductase and risk of fractures among older women
21. HMG-CoA reductase inhibitors and the risk of fractures
22. HMG CoA reductase inhibitors and the risk of hip fractures in the elderly
23. Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomised controlled trial
24. Statin drugs and the risk of fracture [letter]
25. Fatty acid intake and the risk of dementia and cognitive decline: A review of clinical and epidemiological studies
26. Molecular basis of Alzheimer's disease
27. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
28. Statins and the risk of dementia
29. Link between heart disease, cholesterol and Alzheimer's disease: A review
30. Use of lipid lowering medications at discharge in patients with acute myocardial infarction